Some scientists even reported that the expression of ACE2 in a COPD rat group was lower than that in the control group, and that ACE2 could attenuate the COPD inflammatory process induced by cigarette smoke, by reducing oxidative stress and inhibiting NF-κB and p38 MAPK pathway activation [26]. Here, ACE2 is linked to chronic obstructive pulmonary disease.